Monopar Therapeutics  logo
Monopar Therapeutics MNPR
$ 15.75 -7.12%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

Monopar Therapeutics General and Administrative Expenses 2011-2024 | MNPR

Annual General and Administrative Expenses Monopar Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.23 M 2.95 M 2.63 M 2.44 M 2.36 M 1.63 M 1.17 M 912 K - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.23 M 912 K 2.16 M

Quarterly General and Administrative Expenses Monopar Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
658 K - 749 K 733 K 872 K - 675 K 685 K 779 K - 632 K 616 K 688 K - 392 K 632 K 792 K - 540 K 603 K 572 K - 364 K 364 K 440 K - 215 K 283 K 240 K - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
872 K 215 K 569 K